National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the management of acute coronary …

DP Chew, IA Scott, L Cullen, JK French… - Medical Journal of …, 2016 - Wiley Online Library
Introduction: The modern care of suspected and confirmed acute coronary syndrome (ACS)
is informed by an extensive and evolving evidence base. This clinical practice guideline …

Transformative impact of proteomics on cardiovascular health and disease: a scientific statement from the American Heart Association

ML Lindsey, M Mayr, AV Gomes, C Delles, DK Arrell… - Circulation, 2015 - Am Heart Assoc
The year 2014 marked the 20th anniversary of the coining of the term proteomics. The
purpose of this scientific statement is to summarize advances over this period that have …

Validation of the Baveno VI criteria to identify low risk cirrhotic patients not requiring endoscopic surveillance for varices

JB Maurice, E Brodkin, F Arnold, A Navaratnam… - Journal of …, 2016 - Elsevier
Background & Aims The Baveno VI guidelines propose that cirrhotic patients with a liver
stiffness measurement (LSM)< 20 kPa and a platelet count> 150,000/μl can avoid screening …

High-sensitivity cardiac troponin assays: From improved analytical performance to enhanced risk stratification

M Kozinski, M Krintus, J Kubica… - Critical Reviews in …, 2017 - Taylor & Francis
Implementation of cardiac troponin (cTn) assays has revolutionized the diagnosis, risk
stratification, triage and management of patients with suspected myocardial infarction (MI) …

[HTML][HTML] Prognostic value of basal high-sensitive cardiac troponin levels on mortality in the general population: a meta-analysis

N van der Linden, LJJ Klinkenberg, O Bekers… - Medicine, 2016 - journals.lww.com
Interest in the use of cardiac troponin T (cTnT) and cardiac troponin I (cTnI) has expanded
from diagnosis of acute myocardial infarction to risk assessment for morbidity and mortality …

Predicting major adverse events in patients with acute myocardial infarction

T Nestelberger, J Boeddinghaus, D Wussler… - Journal of the American …, 2019 - jacc.org
Background: Early and accurate detection of short-term major adverse cardiac events
(MACE) in patients with suspected acute myocardial infarction (AMI) is an unmet clinical …

Current status of novel biomarkers for the diagnosis of acute kidney injury: a historical perspective

BR Griffin, KM Gist, S Faubel - Journal of intensive care …, 2020 - journals.sagepub.com
Acute kidney injury (AKI) is a common and serious medical condition associated with
significant increases in morbidity, mortality, and cost of care. Because of the high incidence …

Droplet digital PCR as a novel detection method for quantifying microRNAs in acute myocardial infarction

S Robinson, M Follo, D Haenel, M Mauler… - International journal of …, 2018 - Elsevier
Background micro-RNAs have shown promise as potential biomarkers for acute myocardial
infarction and ischemia-reperfusion injury (I/R). Most recently droplet digital polymerase …

Oxidative cross-linking of proteins to DNA following ischemia-reperfusion injury

A Groehler IV, S Kren, Q Li, M Robledo-Villafane… - Free Radical Biology …, 2018 - Elsevier
Myocardial infarction (MI) is a life-threatening condition that can occur when blood flow to
the heart is interrupted due to a blockage in one or more of the coronary vessels. Current …

[HTML][HTML] Diagnostic performance of point-of-care and central laboratory cardiac troponin assays in an emergency department

P Wilke, A Masuch, O Fahron, S Zylla, T Leipold… - PLoS …, 2017 - journals.plos.org
Early diagnosis of myocardial infarction (MI) with cardiac troponin (cTn) assays at the point-
of-care (POC) is suggested to shorten turn-around-time in the emergency department (ED) …